BIOMIT Center for Molecular Immunology - CIM

News


Mostrar

Registros

images/Content/noticias/2d3824fc-5ea1-4a39-998a-b688cd3a991b.jpeg

In an official ceremony on October 1, within the framework of the anniversary of the constitution of the People's Republic of China, the Agreement of Intent for scientific collaboration was signed between the Center for Molecular Immunology, the Cuban-China Biotech Pharmaceutical joint venture and the Government from Changzhi city.


images/Content/noticias/edbde44e-3486-409e-9f12-43a8b83449b0.jpeg

The clinical strategy of the NeuralCIM is currently going through the stage of patient classification for inclusion in the phase 3 clinical trial in mild or moderate Alzheimer's, a study that will be carried out in Havana, once the patient diagnosis process is completed.
For its part, the training workshop on neuropsychological scales applied to Alzheimer's was held, with doctors and researchers from all the provinces of the country, where consultations will soon begin to classify patients for inclusion in the phase 4 clinical trial with NeuralCIM.
The data to request an appointment for the evaluation consultation of the phase 4 clinical trial will be published in the coming days on our website and institutional social networks.


images/Content/noticias/4ae22acf-d58d-421a-804e-0448ec6e853c.jpeg

The European Congress of Oncology ESMOESMO - European Society for Medical Oncology is attended by Dr. Tania Crombet, Clinical Director of the CIM, renowned researchers and oncologists from our country, with the presentation of the most innovative clinical results of the CIMAvax_EGF vaccine.
A unique opportunity to position our science, learn about the state of the art in cancer studies and exchange with scientists from all over the world.


images/Content/noticias/99e48f5c-3b69-4d02-b044-37a9ef6fb193.png

A study is being carried out to evaluate the safety and effect of the drug ior®EPOCIM (produced by the Center for Molecular Immunology), in the treatment of post-COVID-19 convalescent patients with cardiovascular, renal and respiratory sequelae. Cuban subjects of any sex, aged 19 or older, who have suffered from COVID 19 (confirmed by PCR) and who 2 or 3 months later and to date present manifestations such as: Chest pain, rhythm fast heartbeat; Shortness of breath (especially on exertion), cough, difficulty climbing a ladder or hill, difficulty walking long distances; Changes in urine (foamy or bloody urine, more or less urine than usual, or needing to get up at night to urinate), fatigue (feeling more tired and have less energy than usual), dry skin and itching, swelling of the hands or feet, bags around the eyes (especially in the morning), shortness of breath, lower back pain, high blood pressure, poor appetite or nausea and vomiting, difficulty concentrating, trouble concentrating sleep cramps at night.

Diagnosis of these sequelae will be confirmed by computerized axial tomography or other cardiovascular or respiratory function tests, as directed by the study physician. Pregnant or lactating women, or subjects with a history of thromboembolic disease in the last 3 to 6 months, or a history of serious chronic or life-limiting diseases, or who are receiving dialysis or hemodialysis treatment, or have received treatment with an investigational product in the last 6 months. Subjects with mental incapacity that prevents them from understanding the research, signing the participation consent document and complying with the treatment scheme and the evaluations provided for in the study may not be included either.

Two treatment groups will be formed. A group called the "control group" will receive treatment with only conventional therapy. This may include respiratory physiotherapy or other drugs that, according to the doctor's criteria, may be used to treat the cardiovascular, renal or respiratory sequelae under study. The other group called "study group", in addition to conventional therapy will receive 5 administrations of ior®EPOCIM. Subjects are assigned to one or another treatment group by personnel who are not involved in the research, so all subjects will have an equal chance of receiving one treatment or another.
For more information go to:
Province Place where the study consultation is carried out (sites already included) To contact
Havana Hospital October 10
Ground floor of the Mella Pavilion in the Physiotherapy Room Monday-8:30 am-12:00 m
Dr. Yulmys Rodríguez Borges, Physiatry Consultation,
Dr. Abdel del Busto Mesa
Phone: 78776267, ext 261
Pinar del Río Hospital Abel Santamaría 2nd and 4th Monday: Dr. Yusleny Sánchez Orta, Pulmonology
3rd Wednesday. Dr. Yoima González Pérez, Control Consultation 3, Hospital Abel Santamaría
Tuesday morning: Dra. Arlety Pita Valdés, Control Consultation 3, Hosp. Abel Santamaria
Phone 48 762068
Cienfuegos Hospital Gustavo Aldereguía Lima, CEA Tuesday, 8:00 am-12:00 m
General evaluation consultation, every day
Consultation of the CIs:
Lic. Yuleidis García Rodríguez
Lic. Karelia Cortina Naples
Dr. Julio Jova Duenas
Dr. Annia Hernandez Marin
Phone: 43591751
Villa Clara Hospital Arnaldo Milián Lic. Margarita Ríos Cabrera
Dr. Ignacio Ramirez Gomez
Phone: 42 270038
Camaguey Manuel Ascunce Domenech Hospital, Clinical Trials Department (in the basement) Thursday- 9:00 am-12:00 pm
Lic. Judith Ojeda de Pedro
Lic. Yaneidys Lores Méndez
Dr. Yanara Nélida Peláez Guevara
Phone: 32 253856
Holguin Vladimir Ilich Lenin Hospital,
EC Department 1st and 3rd Thursday of each month, 9:00 am
Lic. Kenya Garces Avila
Dr. Irmary Riverón Proenza
Phone: 24 461601
Guantanamo Agostinho Neto Hospital
Clinical Trials Consultation Thursday- 1:00 pm-4:00 pm
Mr. Yadyleidis Elias Oquendo
Lic. Cecilia Sayoux Thaureaux
Dr. Anais González Jarrosay
Dr. Yanet Blanco Robles
Phone: 21 387319
Santiago de Cuba Polyclinic of Specialties attached to the Saturnino Lora Hospital, Clinical Trials Consultation, 3rd Floor, Door 6 Friday, 9:00 am-12:00 m
Dr. Eduardo Rivero Rosales
Lic. Aymara Rosdo
Dr. Juan Carlos Sanchez Moraguez
Phone: 22 645447


images/Content/noticias/c3b7ccbb-f784-40b7-97c8-c93f66f2416a.jpg

Study group: treatment with CIMAvax-EGF® + support therapy
Control group: Only support therapy
Cuban subjects of any sex, older than 19 years of age, who after having had a PCR+, from 2 or 3 months (or more), present signs or symptoms of respiratory disorders will be included.
Frequent manifestations in case of respiratory sequelae: Shortness of breath on exertion as well as difficulty walking long distances.
Patients with mild to moderate respiratory history (for example, bronchial asthma or COPD), compensated prior to PCR+, may be included.
Subjects may not be included if:
- Are pregnant or lactating women.
- Have a history of thromboembolic disease in the last 3 to 6 months.
- Receiving dialysis or hemodialysis treatment,
- Have a history of serious or life-limiting chronic diseases.
- Are receiving or have received any research product in the last 6 months.
- They present evident mental incapacity that prevents them from understanding and signing the consent to participate in the research, and acting accordingly.

Go to:

Province Place where the study consultation is carried out (sites already included) To contact

Havana Hermanos Ameijeiras Hospital
Session 1, Door 2 (in the basement entering through Belascoain)
Take a previous shift at Shift Control (entering through Calle Márquez González) Dra. Denenke Basanta Bergolla (2nd and 4th Mondays 9:00 am-12:00 m)
Dr. Ileidys Rodríguez (1st and 3rd Mondays 9:00 am-12:00 pm)
Dr. Aliuska Aguilar Sosa
Phone: 78765760
Hospital October 10
Ground floor of the Mella Pavilion in the Physiotherapy Room Monday-8:30 am-12:00 m
Dr. Yulmys Rodríguez Borges, Physiatry Consultation,
Dr. Abdel del Busto Mesa
Dr. Yisel Zaldivar Ocampo
Phone: 78776267, ext 261
Salvador Allende Hospital Dra. Yamilka Hernández Sánchez
Dr. Annia Duany
Phone: 78251863, 78744235
Cienfuegos Hospital Gustavo Aldereguía Lima, CEA Tuesday, 8:00 am-12:00 m
General evaluation consultation, every day
Consultation of the CIs:
Lic. Yuleidis García Rodríguez
Lic. Karelia Cortina Naples
Dr. Julio Jova Duenas
Dr. Annia Hernandez Marin
Phone: 43591751
Villa Clara Hospital Arnaldo Milián Lic. Margarita Ríos Cabrera
Dr. Ignacio Ramirez Gomez
Phone: 42 270038
Camagüey Hospital Manuel Ascunce Domenech, Department of Clinical Trials (in the basement) Thursday- 9:00 am-12:00 m
Lic. Judith Ojeda de Pedro
Lic. Yaneidys Lores Méndez
Dr. Oscar Cebrian Rodriguez
Phone: 32 253856
Holguin Vladimir Ilich Lenin Hospital,
EC Department 1st and 3rd Thursday of each month, 9:00 am
Lic. Kenya Garces Avila
Dr. Irmary Riverón Proenza
Phone: 24 461601
Guantanamo Agostinho Neto Hospital
Clinical Trials Consultation Thursday- 1:00 pm-4:00 pm
Mr. Yadyleidis Elias Oquendo
Lic. Cecilia Sayoux Thaureaux
Dr. Maria Antonia Taboada Vila
Dr. Yamila Tabío Ferreiro
Phone: 21 387319
Santiago de Cuba Polyclinic of Specialties attached to the Saturnino Lora Hospital, Clinical Trials Consultation, 3rd Floor, Door 6 Friday, 9:00 am-12:00 m
Dr. Eduardo Rivero Rosales
Lic. Aymara Rosado/Lic. Yaquelin
Dr. Juan Carlos Sanchez Moraguez
Phone: 22 645447


images/Content/noticias/f2ac97e4-9f94-4557-85eb-575d4ba1c5af.JPG

Our Center once again joins the vaccination campaign, this time in pediatric age. For this, in record time, with the help of all the areas of Services, Human Resources, doctors and certified nurses of the Center, all the conditions of a pediatric vaccination were created.
At the same time, we have received the collaboration of Gabi & Sofi and La Colmenita de Cuba, who will complement this process to make this experience an unforgettable moment for the children of our workers and the community.


images/Content/noticias/685bb3bd-6650-4550-bd79-0f2fb9b90b7e.JPG

Our Center receives the ¨Premio del Barrio¨ from the hands of its National Coordinator Gerardo Hernández Cordelo. A recognition based on the CIM's contribution to Cuban health in its more than 25 years of scientific and technological work.
At the same time, the participation of workers from the Center in the confrontation with COVID19, integrating the Henry Reeve Brigades, was recognized.
Support for the vaccination of adults and pediatrics in the community was also recognized, in the CIM certified vaccinations and the promotion of community projects with primary schools for health promotion and care for vulnerable neighborhoods such as La Cantera.


images/Content/noticias/c4ed2ab9-eef7-45c0-bbc7-2bbe135150b9.jpeg

The Cuban Medicines Regulatory Agency CECMED grants the Sanitary License of Pharmaceutical Operations for five years and Certificate of Good Manufacturing Practices to the Productive System of #Soberana.
The License was also granted to the production systems of Bio Cen and our Center, chained to the #Soberanas.
This license is granted by CECMED after an inspection of the production plants and a review of the documentation.


images/Content/noticias/e33fb3de-f0a4-4076-9092-25a10bf50bf9.JPG

Today the CIM received the status of a ¨National Distinguished¨ Center granted by the National Secretariat of the Union of Health Workers.
At the same time they were recognized:
The union vanguards of 2020.
The new militants of the PCC.
The external institutions with an impact on the productive performance of the CIM: Empresas Aguas de la Habana and Sanitation Basic of Havana.
CIM Vaccination Center staff, for the work in health intervention with Soberana02 + SoberanaPlus (Days: 56 / Dose: 5289).


images/Content/noticias/424e120f-a145-44d5-9556-36e522d2a82f.jpeg

This morning we received at our Center the First Secretary of the Central Committee of the Communist Party of Cuba and President of the Republic of Cuba, Miguel Díaz Canel Bermúdez.



At first, General Director Eduardo Ojito Magaz made a presentation on the status of RBD antigen production and explained the challenges that the development of the protein in such a short time has imposed for our group.



Later they went to the interior of the facility (ANTYTER) to verify the productive and technological capacities in which the production of said protein takes place.



At the end of his tour, he exchanged with young researchers linked to the COVID19 Project, to whom he showed his admiration and gratitude for the work carried out in confronting the pandemic, and expressed:



¨Thanks to you we are more sovereign¨


Mostrando 10 de 56 registros
telefono
Phone Board:
53-7-2717933
General Direction:
53-7-2714335
pin
15 Street and 216 Street, Siboney, Playa, La Habana, Cuba. A.P 16040, La Habana 11600, Cuba
pin
Postal Code:
11 600
Post Office Box:
16 040
mapa

Spot

Video

Frequent Questions

How can I access the therapeutic vaccines against lung cancer?


Cuba has 2 therapeutic vaccines for advanced lung cancer: CIMAvax EGF ® and VAXIRA® (Racotumomab). Both therapeutic vaccines have a health record in the indication of advanced non-small cell lung cancer (NSCLC) stage III and IV, after the first line of chemotherapy. The main clinical benefit of these vaccines has been demonstrated in an increase in survival and improvement in quality of life, as well as a broad safety profile. How to get vaccines? Foreigners should contact the Cuban Medical Services who will evaluate each case as part of a comprehensive patient care program, with commercial value. -Cuban Medical Services. Web page: www.smcsalud.cu .; E-mail: smc@smcsalud.cu Telephone: (537) 209-0977 Fax: (537) 203-1590. You can also make your request for care stating the reason for your request, a medical summary and personal data directly to: International Clinic of the Hermanos Ameijeiras Hospital. Calle San Lázaro # 701 esq. a Belascoaín, Centro Habana, La Habana, C.P: 10400, Cuba. Telephone: (537) 8761029, (537) 8761030, (537) 8761683. Email: turismomedico@hha.sld.cu International Health Center - La Pradera Calle 15 e / 222 A y 234, Reparto Siboney, Playa Municipality, Havana, Cuba Telephone: (+537) 273 7467 Ext. 403 (+537) 2737202. Email: comercio@cislapradera.cu   If you want a treatment outside of Cuba. You can contact the following companies with commercial rights in the region for CIMAvax EGF® DELTA Laboratories S.A. Colombia. General Manager: Mr. Alejandro Castaño. Address: Cra. 46 # 19 Sur 117 Medellín, Colombia, South America. Tel. + 57-4-334 40 33. Cell: +57 - 311-301 8257 E-mail: alejandrodelta@deltamedecine.com Skype: Alejandrodelta. URL: www.deltamedicine.com   Libra Laboratorios, Paraguay S.A Commercial Manager: Mr. Pablo Moreira. Address: Pedro Ciancio 1443 between Santiago and San Cosme B Jara Asunción Tel. (595-21) 228 370. Cell: (595) 986 679300 E-mail: pmoreira@lablibra.com

Mas preguntas frecuentes...

Poll

Welcome to the CIM survey, we value your opinion and thank you for dedicating your time

We would love to know how you like our site
Excellent
50% (22897 votes)
Very Good
32% (14763 votes)
Good
5% (2686 votes)
Regular
11% (5099 votes)
Bad
0% (280 votes)